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plasma Iov~ls of tntefleukin (IL) 2, 6 ar¢110, eylokinos which are ablo to affect 
LYMPHO fun~lon and In m0dulato inflammatory proees~u~s, 
Meffmds: Threa groups of pts were studi~: 42 pIS w~m (Idmifted to 
the CCU 13~u~ of on acute lr~tmm~¢ Sy~lrome (AIS group), 36 pie had 
stable ongtna (SA group) and 39 were healthy control subJ(~'ts of equivalent 
age (CTL group), To cl~ra~e~e LYMPHO pbenoM~, flow o/lOmetry was 
pef fO~ in whole, bi0od gmplas ~ l  marx:lanai ~fltibo~te~, IL~, IL.6 
and IL-10 were measured umng ~ ELISA method 
Result" No d ~  was found amtortO lt~e 3 OrO~ l~ the expression 
of C02, C03, CD4, CDa, C019 e~t¢l HLADR m~plom, Double ~nd mple 
ev~ualmn ~t~ an i ~  in C00+C0111~ ~ells (ojlolo=¢ 
T LYMPH<)) a~d in CO16t~O56~COttt~,cetl~ (NK LYMPHO) in tt~ AI$ 
group M~I in ~A OtoUp aS ¢!m~pamd to the CTL group (CD~-CDIlb-*: A!S 
? ~ _2~/~, ~ 0-~ • 1%, c'rL 4,! ± 1%, p ~ 0-05: CDAI~CO~CD!1b*  
AI~ 19,8 :~ 2,3%, SA ~_1.5 ~ !,6%, CTL 6`6 :L 12%, p .~ 0.001), 
W~lhout a~t~tcaity s ~  ~f t~ between A!S at~l SA (;FofllP~- IL-2 
w~ ino, ea~l  in the AtS and SA gn~ aS compared to the CTL group (AIS 
,5.7 ~: O.fl, ~,A 6-5 ± 1.4, CXL ~,4 ± 0,4 pg/ml, p ~ 0.01), whereas Ik.6 WaS 
higher' m tt~ A!S gm~pth#n i  It~ olttm ;~ ~ (AIS 10.8 * 1,?., ~32 ± 
0-,5, CTL ~,0 p ,. 0001). No = t ~  was tour~! between the 3 g ~  m 
the p ~  ~ of !L,t0. 
(~tlCA~:i~tl: These data show II1al ~ wllh ische~ heart disease ha~,e 
an l ~  in eimutalmg cytotot¢ LYMPHO and in IL.2 plasma tewelS as 
~red  Io natural L"(~trOI Stdl~lects. IL'6 =s increased (~ly in pls ~ AIS, 
~ le l tmminuda as a IP~edictor of Coronary  Ar tery  
KR Tuftle, ME. PuNman, S-K. Cooney, LR  Oahtstrm~, T.E. Can~en, 
R~ She~ The Heart Instate at Sp~ane, Spo~t~. Was~mjton, USA 
re,ales to measurable coronan/artery (#rsease (CAD) has not 
been detem~ed. 
/I,~--~=,,~. - In 308 ~ e  patients, u n ~  eleclwe comnaqf on- 
g~:jtald~, alt~mn (RIA) and cma~nine (mo~F~ed JalYe nm) were measured 
m urine lrom an early morning void. The albumin to c,eatimne rafm (ACR) 
wa~ calculated. Fasting plasma msulth (RIA) was n'~asured. Seventy of CAD 
was delemdned by standard ang~jraphtc m~a 
ResuP~: 11~ ACR was 28 ~ 5 in patiertts wffh CAD (n = 242), and 10 _ 1 
in those wdhout CAD (n = 66). p < 0.001. In patmnts ~ (~abeles and CAD 
(n = 37) the ACR was 64 ± 20, cotllpared to 22 ± 4,1 non-dklbe~cs 
CAD (n = 205), p = 0056. Se~ of CAD was related to ACR and insu(in: 
CAD Nag In = 645) I~k::l In = 131 MOd In = 70"1 Severe In = 1591 
ACR (rrg~g) 10 ~: 1 17 = 6 25 • 7" 31 ¢ 6" 
Ir'-c~u~n I~,U.'r~L) 13 : 1 12 ± I 15 ~ 2 24 ~ 4 "? 
Means ~. SE "p * 005vs nego~ r~ld: tp .  005v~ mad 
The odds ratvo (OR) for mcderate or severe CAD was 2.5 (95% C! 1.1-5.6, 
p < 0.05) in those with "mnary albumin >20 moJL: the OR was 2.9 (95% C| 
1.5,--5.9. p < 0.05) if insulin was also >16 .U/mL 
Conc/us/o~s: The presence of CAD and rts seventy is hvghly correlated 
with urinary albumin. The effect LS even greater in diabetes. MA~ with or 
without hyperinsulinemia, presets a high ask of clinK:ally s~gnificant CAD. 
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Background: Lipid Iowenng therapy may improve corenaw vascular funcITon 
by a direct vascular effect of lipid concentration. 
Methods: We investigated the acute effect of a single LDL-apheresis 
(LDL-A) on myocardial pertusion by measuring myocardial bleed flow (MBF 
in ml/min/g) with N-13 ammonia/PET at rest and vasodilatory capacity dunng 
adenosine hyperemia (140 mg/koj'min for 5 rain,) in 10 patients (6 F/4 M) 
with heterozygous familial hypercholesterolemia (FH) and CAD treated with 
weekly LDL-A for 2-10 years. Patients were studied before and after LDL-A; 
each was randomly assigned to PET scan shortly before LDL-A and again 
one day later, or to PET scan just after LOL-A and again prior to LDL-A the 
following week. 
Results: see table. All values are mean ± SD 
The rate-pressure-product remained unchanged at rest and during adeno- 
sine. AlthouQh LDL-A induced a reduction of LDL-Cholesterol by 45%, pa- 
rameters of MBF remained unchanged. 
S(.an I ~n 2 p-v~e 
TotabChol 235 x 3,3 I~9 ~- 18 -0000001 
LOl=~hol 166 ~z 14 ~1~, x 9 ~000(~01 
M~F~,~ 0.88 • 0 31 0 79 ~: 020 ns 
MBF~mo=~e ~48 ~ 0~8 ~2t ~: 082 ns 
CFR ~§9± t 14 ~74 ±076 n~, 
has no instant 0ftect on myocardial r~rlku~n and vasoddatow r, ZK~IIy m 
pat~ w~n FH freat~ w~ wa~y kl~-^. 
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~ N ~ w  Therapeutic Poulb!llty for  ~ l s  A f t~ 
AngloplasW by Inhibit ing Pml l t~ l~/mMne 
~ho~/ l l l l lm of  Focal Adhe l lon  Klmme and 
PmlHlin 
K Miyosh~, V. Nozawa~ E Sasaki, H Terakawa. N Od l  Y Tanahasf,, 
Y. Yamasaki, Y. Murat~zka, H. Mh/aka, N. Ma~uur~L TattOo Ptmtmaoeutcal 
~ of smoom muscJe cegs (SMC) ceumng neomema ~ ~ 
known 1o be ( ~ .  on p~olefn-tyresine ~ (PTP) of focal 
TAS-30I, ,3~~Jmethy /ene-2~inone,  on FAK actlon m 
neomt~ma fonnalmn attar ~ mlmy In a rat balloon m~uly model, oral 
al~icalmfl of TAS-3OI s@11ficanfly reduced the number of Oa0s that migrated 
to llm lumen surface (at 100 m~,  50 ~ 5 (SD) ve. 95 :t: t5c~,  P < 
0.01) and the ratio of ml~ma ~ area ina d o ~  mlz, lx1~. 
In a modified Bo~n chamber a~aay, TAS-301 do~- ,x3~, -ay  intifll~ed 
ttte mKjratmn of rat Fg~lCinmspormetoPDGF.BB(at 3pM.65 ± 30,m 146 
± 14 ceg~4HPF, p < 0.01). Western blot ana~ with a n ~ n e  
antlt~,dy ~ that TAS..301 at 10 pM Inhd~led PTP of FAK (0.81 ± 0.12 
vs. 122 :~ 0.22-fold increase agaJnsl the control level, P < 0.05) and of 
ipaxillin (2.4 ¢ 0.7 vs. 4.4 ± 0.9, P < 0.01), ~ not that of PDGF-p r~or ,  
in rat SMC sllmulated by F~GF-BB. 
These data su~ that PTP of FAK and paxillin Ls a causally related to 
the migration phase of SMC du~ neo=r~ma formalin, n. and also s~gest 
ff~e r~w therapeubc poss~blltty ofTAS-301 for mslenosvs after angloplasty 
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Surgery. University Zurich. S~tzedand 
Back~z:~:/: I~  ondothelin-1 (big ET-I) ~s coflverled to en~othattT~l by en- 
dotheltn co~wertmg enzymes OECE). previous sludies suggested that this 
conversion can be inhibited by the metalloprotease tnhll~for I~mi -  
don. 
Methods: Funct~ot~at ECE actnnty was studt~:l in isolated human arteries 
,/.,nZen~ I m~mmap,.P, .,;~,, ~ ~ ~,~'.~,t~p,,. P~ ~'ve~r~ ~,taw~mwe~, 
SV) in organ chambers. Express~on of ECE-1 was analyzed by RT-PCR in 
cultured smooth muscle cells. 
Results: Big ET-1 (1-100 nrnat/L) mo'ucad srmila~ contracllons in SV with 
(+E) or wdhout endothelium (-E) (+E: 62 ± !P/= of KCI; -E: 58 ± 7%; n = 
7), which were sK:jnificantly reduced (Out not prevented) by the ECE inhib,~or 
phospheramidon (0.1 mmol/L) (+E: 31 + 7%; -E" 27 ± 8%; p < 0,05 vs 
controls; +E./-E: n.s.), Big ET-I induced simdar responses in IMA (+E: 58 ± 
9%; -E: 51 :~ 9%: n = 7). In contrast, contractions were higher in RA (+E: 77 
± 9%; -E: 68 ± 10%: n = 7; p < 0.01 vs controls). While phosphommidon 
attenuated big ET-1 contractioP.s in IMA (+E: 40 ± 9%; -E: 38 ± lf%; p < 
0.05 vs controls), it did not affect responses in RA (+E: 79 ~ 8%; -E: 70 
+ 12%). ET-1 tissue content was significantly elevated in RA and IMA (p < 
0.001 vs SV). ECE-1 m.RNA could be detected in vascular smooth muscle 
cells of all arteries and veins investigated. 
Conclusions: These data demonstrate that (1) big ET-1 induces endethe- 
lium.indeper,~=mt contractions in human vessels and that (2) conversion of 
big ET-1 to ET-I is mediated by phosphoramidon-sensitive and insensitive 
~q.,%. -~Wlm-a~y :'n, -s'nlt.~ ~ -n~J~ ~:",~- '-Fi~'c~, " , "~ '~'~'~'~,~ `Y~&~'~=Cz~ 
